A prostate cancer susceptibility locus (HPC1) at 1q24-25 has been identified. Subsequent analysis showed that the majority of the evidence for localization was provided by families with relatively young (<65 years) average age at diagnosis. We examined evidence for linkage to this region in a set of 41 extended multi-case prostate cancer pedigrees containing 440 prostate cancer cases. Genotyping of five short tandem repeat markers in the region was performed on DNA from 1724 individuals, including 284 prostate cancer cases. In comparison with the families reported in the initial localization, the Utah pedigrees are generally much larger (average of 10.7 versus 5.1 cases) and have an older average age at diagnosis (69 versus 65 years). Two-and three-point linkage analyses were conducted using a previously reported model and provided replication for HPC1 (twopoint: LOD = 1.73, P = 0.005 at D1S196; three-point: LOD = 2.06, P = 0.002 for the interval D1S196-D1S416). The youngest quartile (by median age at diagnosis) yielded a maximum LOD of 2.82, P = 0.0003 (at D1S215-D1S222), compared with a maximum LOD of 0.73, P = 0.07 for the oldest quartile pedigrees at the same locus. Further analysis with an age-dependent model, specifying higher sporadic rates for older cases, suggests that the linkage evidence may be lower than expected given the power of the resource due to a high sporadic rate in the large Utah pedigrees.
INTRODUCTION
Prostate cancer is a pervasive disease in the USA, with an estimated 184 500 cases diagnosed in 1998 (1) . It is the most commonly diagnosed cancer in men in the USA and the second most common cause of cancer mortality, with an estimated 39 200 deaths in 1998 (1) . Approximately one in five men will be diagnosed with prostate cancer over the course of his lifetime. The risk of prostate cancer is greatly increased after age 65 years, with 80% of the cases diagnosed in men after this age. Risk factors for prostate cancer include age, ethnicity, country of origin and family history (2) . Woolf (3) described a relative risk of 3.0 of developing prostate cancer among first-degree relatives of prostate cancer cases in Utah using death certificate data. More recently, relative risks ranging from 3 to 11 for first-degree relatives of prostate cancer cases have been reported (4) (5) (6) (7) (8) (9) . Relative risks rise markedly with decreasing age of the index case (10, 11) and with increasing number of prostate cancer cases within the family (12) .
The familiality of prostate cancer cases in the Utah population has been well studied. When the familiality of major cancer sites was reviewed, prostate cancer was one of the most familial of the common cancers, ranking above both breast and colon cancers (4, 10) . An excess of both close and distant relationships was observed, suggesting that not only shared environmental factors, but a genetic predisposition may contribute to prostate cancer incidence in these pedigrees.
Carter et al. (12) performed segregation analysis on Caucasian families ascertained through a single prostate cancer proband. The analysis suggested Mendelian inheritance in a subset of families through autosomal dominant inheritance of a rare (q = 0.003), highrisk allele with estimated cumulative risk of prostate cancer for carriers of 88% by age 85 years. Inherited prostate cancer susceptibility accounted for a significant proportion of earlyonset disease, and overall was responsible for 9% of prostate occurrence by age 85 years. Schaid et al. (13) replicated those results and, in addition, concluded that because the parameter estimates varied across the different age groups, genetic heterogeneity is present. In segregation analysis of a Swedish population-based sample of families (14) , the clustering of prostate cancer was also explained by a dominant model, but with allele frequency of 0.0167 and lifetime penetrance of 63%. The strong evidence for a familial effect on risk of prostate cancer, coupled with the evidence for Mendelian segregation, has long suggested that inherited susceptibilities play a role in the etiology of the disease.
Smith et al. (15) reported the first localization of a putative prostate cancer susceptibility gene, HPC1, to chromosome 1q24-25. They examined 91 families with an average number of 4.9 prostate cancer cases per family and an average age at diagnosis of 65 years. Accounting for genetic heterogeneity, they reported a maximum multipoint LOD score of 5.43, P = 0.00000059 and estimated that one-third of their families were linked to the region. In a further analysis, Grönberg et al. (16) reported that the evidence for linkage was primarily from families with at least five prostate cancer cases and an early average age at diagnosis.
Four replication studies have been published, with mixed results. Lander and Kruglyak (17) have recommended a P < 0.000049 (LOD > 3.3) to declare significant linkage initially, and a P < 0.01 for replication of significant linkage. This threshold is reasonable for replication of significant linkage because it reflects a nominal P-value of 0.05 with correction for a modest number of multiple tests (~5 We present an examination of linkage to 1q24-25 in a set of 41 high-risk prostate cancer pedigrees from Utah that were ascertained on the basis of familial clustering of the disease.
RESULTS
We examined evidence for linkage to HPC1 in 41 informative high-risk prostate cancer pedigrees using five short tandem repeat (STR) markers in the 1q24-25 region examined by Smith et al. (15) (Table 1) . Results from analyses employing the model used by Smith et al. (15) and an age-dependent model were similar. LOD scores for both models are shown in Tables 2-4 . Two-point LOD scores for the 41 pedigrees replicated the HPC1 localization. The maximum LOD was 1.73, P = 0.005 (Smith) and 1.92, P = 0.003 (Age) at D1S196 ( Table 2 ). Ott's admixture test (22) was unable to detect heterogeneity, so the proportion of linked pedigrees (alpha) could not be estimated. A series of three-point analyses produced a maximum LOD of 2.06, P = 0.002 (Smith) and 2.43, P = 0.0008 (Age) at D1S196-D1S416, providing stronger evidence for replication of linkage (Table 2) . Again, the admixture test failed to distinguish linked and unlinked pedigrees.
In order to investigate the finding of Grönberg et al. (16) that HPC1 is associated most strongly with prostate cancer diagnosed at an early age, the 41 pedigrees were divided into quartiles by ascending median age at diagnosis for all prostate cancer cases (Table 5) , and LOD scores for the youngest and oldest quartiles were calculated (Table 3) . Two-point LOD scores were higher in the youngest group (n = 9) than the oldest group (n = 10) for all but D1S196, and were much higher for D1S222 [LOD = 2.44, P = 0.0008 (Smith), LOD = 1.94, P = 0.003 (Age) versus LOD = 0.11, P = 0.48 (Smith), LOD = 0.27, P = 0.27 (Age)]. Marker D1S222 is positioned very close to the multipoint peak of LOD published by Smith et al. (15) . Threepoint LOD scores also were generally higher for the youngest group (Table 4) , with a maximum LOD of 2.82, P = 0.0003 (Smith) and 2.59, P = 0.0006 (Age) at D1S215-D1S222, and 1.91, P = 0.003 (Smith) and 1.87, P = 0.003 (Age) at D1S222-D1S422.
DISCUSSION
Smith et al. (15) presented evidence for a major prostate cancer susceptibility locus on chromosome 1, suggesting that it may explain as much as one-third of familial prostate cancer. We have investigated this hypothesis in a set of extended, high-risk prostate cancer pedigrees collected in Utah over the past 9 years. We report the first replication of linkage to HPC1 with both two-and three-point analyses, and provide stronger evidence among our younger age at diagnosis pedigrees. Although the highest LOD scores in the overall analyses were obtained with markers located some 15 cM proximal to the most likely locus reported by Smith et al. (15) , the LOD score maximized at a recombination fraction of 0.30 (Smith) and 0.20 (Age), indicating linkage to a disease gene at some genetic distance away. Stronger linkage evidence is provided by the two-and three-point LOD scores of youngest quartile kindreds, maximizing close to the position indicated by Smith et al. (15) . Although the LOD scores resulting from our analyses are adequate to replicate linkage to HPC1 at 1q24-25 as a familial prostate cancer locus, they fail the LOD >3.0 or 3.3 criterion traditionally used to support a new localization. We estimated the power of our resource to detect linkage by calculating expected LOD scores (ELODs) and found that several pedigrees are able, by themselves, to generate LOD scores >2.0 under the condition of no model misspecification. We hypothesize that the lower than might be expected HPC1 evidence, given the power of the resource, is due to several factors related to model misspecification.
Some pedigrees in our resource may, in fact, be linked to HPC1, but we are unable to detect linkage in them due to non-HPC1 cases not accounted for by the genetic model. Because prostate cancer is a common disease and these kindreds were selected for an excess of prostate cancer, non-genetic and non-HPC1 cases are more likely to be observed in these large kindreds. The presence of sporadic (non- (Tables 2-4 ). The Age model specifies higher sporadic rates than the Smith model, in particular for prostate cancer cases diagnosed at older ages, suggesting that sporadics are modeled more appropriately by the Age model. On the other hand, the LOD scores under the Age model are not always larger than LOD scores under the Smith model, indicating that although sporadics may be accounted for better in the Age model, the power to detect linkage is decreased.
Some research groups have had only marginal success in replicating the HPC1 locus (20, 21) . Other groups observed negative evidence for linkage (18, 19) . It is unclear whether these mixed results (Table 6 ) are due to HPC1 accounting for a much smaller proportion of prostate cancer than Smith et al.'s (15) estimate of 35%, or due to the inability to identify sporadics or model them appropriately. This is especially true given that locus or allelic heterogeneity has an effect on LOD scores similar to that of genuine sporadics. The estimate of the true proportion of families with prostate cancer due to HPC1 will require cloning of the gene and identification of mutations within the families.
Grönberg et al. (16) suggest that families with a younger age at diagnosis and with a higher density of cases are more likely to be linked to HPC1. In the four previous replication studies, regardless of the overall evidence of linkage, when the data sets were stratified and analyzed, families with either a larger number of cases or an earlier age at diagnosis produced better evidence for linkage than did pedigrees with older average age at diagnosis or with fewer cases. However, even with stratification, they were unable to replicate the HPC1 localization (Table 6 ).
In large Utah pedigrees, we were able to replicate the HPC1 localization and to replicate the finding that stronger evidence is found in those pedigrees with younger ages at diagnosis (Table 6 ).
Other prostate cancer susceptibility loci probably exist and may be responsible for a higher proportion of older age at diagnosis familial prostate cancer. Three prostate cancer linkages have been published at 1q42-43 (23), Xq24 (24) and 1p36 (25) , suggesting three additional prostate cancer susceptibility genes. Analyses of these loci are underway. Most of the Utah pedigrees with the greatest power to detect linkage showed little to no evidence of HPC1 linkage and are being tested for linkage to these other putative loci. These pedigrees will provide an excellent resource for the replication of these localizations and possible new linkages as well.
MATERIALS AND METHODS

Ascertainment of pedigrees
High-risk prostate cancer pedigrees were ascertained from the Utah Population Database, which combines about eight generations of genealogical data from Utah pioneers and their descendants, and~30 years of complete cancer registration for the state of Utah (26, 27) . All of the Utah pedigrees studied represent the descendants of a single founder for whom a significant excess of prostate cancer cases was observed among all descendants. A total of 3502 such independent clusters of prostate cancer have been identified, ranging in size from two to 62 prostate cancer cases per cluster. In 1990, we began collecting blood samples in 298 of these clusters. Because these clusters are defined only by an excess of prostate cancer, there is no bias towards early age at diagnosis or number of affected first-degree relatives. Furthermore, because all affected descendants are studied, the resulting pedigrees represent a collection of both closely and distantly related prostate cancer cases.
Genotyping for the set of markers at 1q24-25 has been completed in 54 pedigrees. A subset of these 54 pedigrees was selected for inclusion in linkage analysis based on power to detect linkage as evidenced by ELOD. For each family, a single marker was simulated for genotyped individuals. An age-dependent model (Table 7) with a rare disease allele (frequency = 0.003), a marker with six equally frequent alleles and a penetrance function dependent on age and affection status was used for simulation. The disease-marker linkage was simulated with θ = 0.05. This model was also used for analysis of the simulated data. The software programs SLINK and MSIM (28) were used for simulation and analysis, respectively. The minimum criterion for inclusion of a family for linkage analysis was that the average ELOD + 1 SD was >0.3. This metric ranged from 0.31 to 2.42 for the selected pedigrees. Maximum ELOD values ranged from 0.40 to 3.66.
The 41 Utah pedigrees that met this criterion are typical of the larger set of Utah pedigrees studied. They are 3-7 generations deep and contain between four and 26 prostate cancer cases in the branches of the pedigrees that were genotyped (Table 5 ). All are Caucasian of Northern European ancestry. The median age at diagnosis for each family ranged from 62 to 77 years, with an average median of~69 years, similar to that estimated for the general Utah population. The mean age at diagnosis of prostate cancer in these pedigrees is generally older (69.0 versus 64.9 years) than the resource studied by Smith et al. (15) . Only 29 prostate cancer cases (4.5%) were diagnosed before age 55 years in the 41 pedigrees. All participants signed informed consent documents. This research project has the approval of the University of Utah School of Medicine Institutional Review Board. Blood samples were gathered from all available males with prostate cancer and all of their available connecting ancestors. Ninetyseven percent of cancer cases have been confirmed through medical record (and/or through the Utah Cancer Registry for prostate cancer cases diagnosed in Utah). Where prostate cancer cases were deceased, spouse and offspring were sampled to infer the genotype of the case. Because parents of cases were seldom available, multiple siblings or a single offspring were sampled to improve phase inference.
Genotyping
Nuclear pellets were extracted from 16 ml of blood, and DNA extracted with phenol and chloroform, precipitated with ethanol and resuspended in Tris-EDTA. PCR amplification was performed with fluorescently labeled primers. Sizing of the PCR products was performed on the automated ABI377 (Applied Biosystems, Foster City, CA), using modifications of the programs GENESCAN and GENOTYPER. Size standards were included in every lane, and one common control individual was included on each gel.
The markers used for genotyping were STR loci at 1q24-25 that flanked the most likely HPC1 location as indicated in Smith et al. (15) . The markers included in our analyses were selected for completeness of genotyping and informativeness and are, for the most part, different from those utilized by Smith et al. (15) . A map containing both sets of markers is presented in Table 1 .
Linkage analysis
Two-point linkage analysis was performed with the package LINKAGE (29) using the FASTLINK implementation (30, 31) . The statistical analysis for the inheritance of susceptibility to prostate cancer used a model, referred to here as the Smith model (15) , that assumes a phenocopy rate of 15%, regardless of age, and treats unaffected men under the age of 75 years, as well as women, as having unknown phenotype. In men over age 75 years, the lifetime penetrance of gene carriers according to this model is 63%. A second model, referred to here as the Age model, was developed using age-specific incidence rates from the Utah Cancer Registry, assuming a relative risk of 2.5 for first-degree relatives. In both models, susceptibility to prostate cancer was assumed to be due to a dominant allele with a population frequency of 0.003. The Age model is thought to represent better the risk of prostate cancer in the Utah population. The liability classes for the two models are shown in Table 6 . Females are classified in the lowest unaffected class. Marker allele frequencies were estimated from unrelated individuals present in the pedigrees.
Linkage in the presence of heterogeneity was assessed by the admixture test (A-test) of Ott (22) , using HOMOG, which postulates two family types, linked and unlinked. Three-point linkage analysis was performed using VITESSE (32) . The size of our pedigrees, as well as the number of individuals not genotyped in upper generations, made simultaneous analysis of more than two markers and the disease impossible. Non-parametric multipoint linkage analyses with GENEHUNTER (33) required such extensive reduction of the kindreds as to render the results uninformative.
It has been demonstrated that model misspecification in a multipoint context results in disease localization being 'pushed outside' the set of markers analyzed (34) . Therefore, a three-point analysis for each adjacent pair of markers was performed, rather than a 'walking' three-point analysis that only calculates LOD scores in intervals between pairs of interior markers. This strategy allows for LOD scores to maximize outside all pairs of markers and improves the chance of finding evidence for linkage, even in the presence of model misspecification. Because the purpose of our analysis was to provide replication of the linkage, rather than to map the location of the HPC1 gene within the region, this strategy seemed appropriate.
